DexCom, Inc. (DXCM) vs Edwards Lifesciences Corporation (EW)
DexCom, Inc. and Edwards Lifesciences Corporation are both Medical Devices companies. Edwards Lifesciences Corporation is the larger, with a market value of $49.4B against $33.0B — 1.5× the size. DexCom, Inc. trades at the lower P/E: 33.4× against 49.6×. DexCom, Inc. grew revenue faster over the last twelve months: 15.5% against 14.6%. DexCom, Inc. has the higher net margin (20.1% vs 15.4%) and the higher return on invested capital (37.1% vs 12.8%). Across the 22 metrics below, DexCom, Inc. leads on 17 and Edwards Lifesciences Corporation on 5.
Valuation
Profitability
| Metric | DXCM | EW | Medical Devices median |
|---|---|---|---|
| Gross margin | 62.47% | 77.84% | 56.01% |
| Operating margin | 22.92% | 22.25% | (15.03%) |
| Net margin | 20.12% | 15.43% | (20.40%) |
| Free cash flow margin | 28.27% | 22.01% | (7.24%) |
| Return on equity | 38.49% | 9.42% | (15.32%) |
| Return on assets | 14.51% | 7.35% | (19.72%) |
| Return on invested capital | 37.13% | 12.81% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack